Johnson & Johnson Projects Aim to Spot Who’ll Get a Disease

LINDA A. JOHNSON, AP Business Writer TRENTON, N.J. (AP) — Imagine being able to identify who is likely to develop a particular disease — and then stop the disorder before it starts. That’s the goal of three research projects launched by Johnson & Johnson’s pharmaceutical Read More